Default company panoramic image
Da13e424 0e96 43ac 93ba d9728a33417c


Automating the detection and tracking of movement disorders using the Microsoft Kinect.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Employees 3
  • Website

Company Summary

Tracking involuntary movement disorders is notoriously difficult for doctors. Tests for these disorders are subjective and difficult to perform reliably. KAMAS's goal is to provide simple, cheap, accessible technology that can automate the performance of these tests in the patient's home.